Our Mission
Accelerating personal genomics by providing an open standard platform
to enable scalable and secure genomic 2.0 applications.
(based on the only ISO genomic standard, which we significantly contributed to shape)
Our history
GenomSys is a Swiss health software company aiming at accelerating genomics and precision medicine by providing innovative digital-age applications for genomic data processing and analyses.
Founded in 2016 by a group of experienced engineers and bioinformaticians, the company is a pioneer in the development of open standards for genomic data storage and processing and in the implementation of compliant software and tools for its effective application.
GenomSys led and substantially contributed to the development and publication in 2020 of the new and only ISO standard for genomic data (ISO/IEC 23092 MPEG-G, “the MP3 equivalent for genomic data”), fostering innovation and interoperability.
More recently, GenomSys developed a software toolkit (GenomSys MPEG-G Tool Kit), enabling everyone to benefit from the new standard and an intuitive germline analysis platform (GenomSys Variant Analyzer) for genomic labs.
In 2024, we incorporated our subsidiary GenomSys Srl in Italy and established the MPEG-G Competence Center in Milan, where a team of computer engineers and bioinformaticians advances the development of the standard, creates cutting-edge software solutions, and provides technical support to our clients worldwide.
Investors
Romed SpA
Romed SpA is a single-family office founded in 1985.
The company focuses on managing a basket of liquid investments across all asset classes, such as FX, Equity, and Bonds, as well as a portfolio of commitments to various VC firms.
Club degli Investitori
Club degli Investitori is the most active business angel network in Italy. Started in Turin in 2008 by four entrepreneurs, Club degli Investitori represents today a novel model of investing in Italy. More than 170 member investors invested with 16 million Euro on a portfolio of 25 companies and completed 3 exits. In 2018, Club degli Investitori invested more than 3 million Euros, with a goal of 5 million euros in 2019.
Elysia Capital
Elysia Capital is the single Family Office of the Buono-Lopera family based in London and Turin. Sustainable innovation, uniqueness, social well-being, know-how: these are the keywords we seek in the projects we support, as we think that good ideas can really change the world. We believe in the value of know-how, in expertise and in teamwork.
Our mission is to turn sustainable projects into great enterprises by investing in their evolution as a means to improve social well-being. Our Company invests mainly in the field of sustainable Innovation, Education, Well-being, Arts and Culture.
Diagnóstica Longwood
Diagnóstica Longwood offers its clients a wide range of products and technologies for in vitro diagnostics and research in laboratories of Immunology, Transplant, Genetics, Hematology, oncology and Blood Banks among others. In recent years, molecular diagnostics has been the core of the company’s commercial and technical activity.
The company stands out for its great team of highly qualified professionals, who respond quickly and efficiently to the needs of the customers, both in the national territory and abroad. This personalized attention is part of the DNA of the team and one of the strategic values of the company.
HandsOnGen
HandsOnGen is a research & development, and consulting company that unites a team of professionals from highly diverse sectors — all sharing the same DNA of innovation.
At its core lies the concept of a fusion of operational excellence and managerial expertise that powers an active consulting model — a hands-on, results-oriented approach combining cross-disciplinary creativity with strategic insight.








